Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1975 May;11(5):1122–1132. doi: 10.1128/iai.11.5.1122-1132.1975

Susceptibility of thymectomized and irradiated mice to challenge with several organisms and the effect of dapsone on infection with Mycobacterium leprae.

L Levy, H Ng, M J Evans, J L Krahenbuhl
PMCID: PMC415187  PMID: 804443

Abstract

B6C3F1 mice that had been thymectomized at 8 to 12 weeks of age, subjected to 950 R of whole-body X irradiation, and transfused with syngeneic bone marrow were challenged in a footpad with Mycobacterium leprae or M. marinum, or intravenously or intraperitioneally with Listeria monocytogenes. Also, mice inoculated with M. leprae in a hind footpad were administered dapsone in the mouse chow. The thymectomized-irradiated (T + R) mice did not survive as well as non-thymectomized mice when housed in the vivarium with no special precautions, but survived sufficiently well to permit the completion of some long-term experiments. M. leprae multiplied to a higher "ceiling" and survived longer in the T + R mice than in the non-thymectomized controls. But a ceiling to multiplication of M. leprae was imposed, and finally the organisms were killed. The histopathological appearance of the footpad tissues, studied by electron microscopy, was consistent with the measurements of bacterial numbers and viability. Swelling of the footpad after local inoculation with M. marinum was greater in T + R mice than in non-thymectomized controls. Similarly, the number of L. monocytogenes following intravenous challenge was greater in the spleens of T + R than of non-thymectomized mice, and the survival of the T + R mice was impaired after intraperitoneal challenge with L.monocytogenes, compared to the survival of non-thymectomized mice. None of these differences was striking, suggesting that these T + R mice had retained or regained some immune competence. The effects of dapsone treatment of T + R mice inoculated with M. leprae were much the same as those of treatment of non-thymectomized mice. Because these T + R mice were not greatly immunosuppressed, they would not have provided a model of human lepromatous leprosy suitable for chemotherapeutic studies.

Full text

PDF
1122

Images in this article

1125Image
on p.1125
1126Image
on p.1126
1127Image
on p.1127
1128Image
on p.1128

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Evans M. J., Levy L. Ultrastructural changes in cells of the mouse footpad infected with Mycobacterium leprae. Infect Immun. 1972 Feb;5(2):238–247. doi: 10.1128/iai.5.2.238-247.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Evans M. J., Newton H. E., Levy L. Early response of mouse foot pads to Mycobacterium laprae. Infect Immun. 1973 Jan;7(1):76–85. doi: 10.1128/iai.7.1.76-85.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Levy L., Biggs J. T., Jr, Gordon G. R., Peters J. H. Disposition of the antileprosy drug, dapsone, in the mouse. Proc Soc Exp Biol Med. 1972 Jul;140(3):937–943. doi: 10.3181/00379727-140-36584. [DOI] [PubMed] [Google Scholar]
  4. Levy L. Death of Mycobacterium leprae in mice, and the additional effect of dapsone administration. Proc Soc Exp Biol Med. 1970 Dec;135(3):745–749. doi: 10.3181/00379727-135-35134. [DOI] [PubMed] [Google Scholar]
  5. Levy L., Moon N., Murray L. P., O'Neill S. M., Gustafson L. E., Evans M. J. Studies of the mouse foot pad technic for cultivation of Mycobacterium leprae. 1. Fate of inoculated organisms. Int J Lepr Other Mycobact Dis. 1974 Apr-Jun;42(2):165–173. [PubMed] [Google Scholar]
  6. Levy L. Pharmacologic studies of clofazimine. Am J Trop Med Hyg. 1974 Nov;23(6):1097–1109. doi: 10.4269/ajtmh.1974.23.1097. [DOI] [PubMed] [Google Scholar]
  7. Levy L. Prolongation of the lag phase of Mycobacterium leprae by dapsone. Proc Soc Exp Biol Med. 1972 Jan;139(1):263–266. doi: 10.3181/00379727-139-36123. [DOI] [PubMed] [Google Scholar]
  8. Levy L. The effect of freezing and storage at -60 degrees C on the viability of Mycobacterium leprae. Cryobiology. 1971 Dec;8(6):574–576. doi: 10.1016/0011-2240(71)90010-1. [DOI] [PubMed] [Google Scholar]
  9. Ng H., Jacobsen P. L., Levy L. Analogy of Mycobacterium marinum disease to Mycobacterium leprae infection in footpads of mice. Infect Immun. 1973 Dec;8(6):860–867. doi: 10.1128/iai.8.6.860-867.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rees R. J. Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae. Nature. 1966 Aug 6;211(5049):657–658. doi: 10.1038/211657a0. [DOI] [PubMed] [Google Scholar]
  11. Rees R. J., Weddell A. G. Biology of the mycobacterioses. Experimental models for studying leprosy. Ann N Y Acad Sci. 1968 Sep 5;154(1):214–236. doi: 10.1111/j.1749-6632.1968.tb16711.x. [DOI] [PubMed] [Google Scholar]
  12. SMITH C. E. G., WESTGARTH D. R. The use of survival time in the analysis of neutralization tests for serum antibody surveys. J Hyg (Lond) 1957 Jun;55(2):224–238. doi: 10.1017/s0022172400037128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Shepard C. C. A survey of the drugs with activity against M. leprae in mice. Int J Lepr Other Mycobact Dis. 1971 Apr-Jun;39(2):340–348. [PubMed] [Google Scholar]
  14. Shepard C. C., Chang Y. T. Effect of DDS on established infections with Mycobacterium leprae in mice. Int J Lepr Other Mycobact Dis. 1967 Jan-Mar;35(1):52–57. [PubMed] [Google Scholar]
  15. Shepard C. C., Congdon C. C. Increased growth of Mycobacterium leprae in thymectomized-irradiated mice after foot pad inoculation. Int J Lepr Other Mycobact Dis. 1968 Apr-Jun;36(2):224–227. [PubMed] [Google Scholar]
  16. Shepard C. C. Immunologic suppression in leprosy and its relation to lepromatous disease. Int J Lepr Other Mycobact Dis. 1968 Jan-Mar;36(1):87–90. [PubMed] [Google Scholar]
  17. Shepard C. C., Levy L., Fasal P. The death rate of Mycobacterium leprae during treatment of lepromatous leprosy with acedapsone (DADDS). Am J Trop Med Hyg. 1972 Jul;21(4):440–445. doi: 10.4269/ajtmh.1972.21.440. [DOI] [PubMed] [Google Scholar]
  18. Shepard C. C., McRae D. H. A method for counting acid-fast bacteria. Int J Lepr Other Mycobact Dis. 1968 Jan-Mar;36(1):78–82. [PubMed] [Google Scholar]
  19. Shepard C. C. The first decade in experimental leprosy. Bull World Health Organ. 1971;44(6):821–827. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES